Review
Copyright ©The Author(s) 2023.
World J Gastroenterol. Aug 7, 2023; 29(29): 4499-4527
Published online Aug 7, 2023. doi: 10.3748/wjg.v29.i29.4499
Table 3 Implications of defects in adenosine triphosphate synthase subunits on bioenergetic alterations and the development or progression of gastrointestinal cancer
TypeGeneType of defectConsequenceModelRef.
GCATP5F1BIncreased in tumorHigher ATP5B expression correlated with poor prognosis. Over-expression of ATP5F1B increased intracellular and extracellular ATP levels, cell proliferation, migration, and invasionGC patient, cell line, and xeno-transplantation mouse model[107]
GCATP5F1BReduced in tumorReduced ATP5F1B expression correlated with elevated glycolytic enzyme levelsGC patient[108]
HCCATP5F1BReduced in tumorReduced ATP5F1B expression correlated with impaired OXPHOSHCC patient[109,110]
ESCAATP5F1BReduced in tumorReduced ATP5F1B expression correlated with elevated glycolytic enzyme levelsESCA patient[108]
CRCATP5F1BReduced in tumorReduced ATP5F1B expression correlated with poor prognosis in CRC patientsCRC patient[109]
PACATP5F1BReduced in tumorUnknownPAC patient and cell line[111]
CRCATP5F1AIncreased in liver metastasized tumorSilencing of ATP5F1A inhibited cell invasion and reduced cell proliferation in CRC cancer cellsCRC patient and cell line[112]
CRCATP5F1EIncreased in tumorHigher ATP5E levels correlated with poor prognosis. Silencing of ATP5F1E inhibited cancer cell migration and invasion in vitro, and distal metastasis in vivoCRC patient, cell line, and tail vein injected mouse model[113]
CRCATP5F1DIncreased in liver metastasized tumorHigher ATP5F1D expression correlated with poor prognosis, and silencing of ATP5F1D inhibited cell invasionCRC patient and cell line[112]